Colgate Q4 organic sales +8.5%; GAAP EPS $2.13 (-16%) on Filorga impairment

COLGATE PALMOLIVE CO

2022-FY EPS reported $2.13 revenue$17,967,000,000

Q4 net sales +5.0%, organic sales +8.5%, with growth in every division and category.
Full year net sales $17,967M (+3.0%), organic sales +7.0% – fourth consecutive year above 3–5% target.
GAAP EPS $2.13, down 16% YoY, driven by goodwill/intangibles impairment charges on Filorga skin health business.
Base Business (non-GAAP) EPS $2.97, down 7% YoY, in line with full-year guidance.
Management cites revenue growth management and productivity initiatives funding increased innovation and advertising.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

COLGATE PALMOLIVE CO reported financial results for the quarter and year ended December 31, 2022.

Period: the quarter and year ended December 31, 2022
Result: reported results

Exact text from the filing

On January 27, 2023, Colgate-Palmolive Company (the "Company") issued a press release announcing its earnings for the quarter and year ended December 31, 2022.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

COLGATE PALMOLIVE CO filing history →

Source: SEC EDGAR

accession 0001157523-23-000106

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.